Friday, November 9, 2018

AmerisourceBergen's compounding site still on ice despite beefed-up oversight - BioPharma Dive

-----

-----

Read the full article:

AmerisourceBergen's compounding site still on ice despite beefed-up oversight - BioPharma Dive

"PharMEDium, a drug compounder and subsidiary of AmerisourceBergen, received a series of Form 483s over the last year as regulators observed issues at several of its manufacturing plants. Some of the more common issues included failing to have procedures that adequately protect against contamination or ensure quality control."

Return Home:  The Designated Representative and Exemptee Blog

---------------

Root Cause Analysis and Deviation Investigation Report Writing - An online self-study FDA cGMP training
Root Cause Analysis and Deviation Investigation Report Writing - An online self-study FDA cGMP training course


For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

No comments:

Post a Comment

Custom Search

From SkillsPlus International Inc.